An open-label, randomized, multicenter dose-finding study of once-per-cycle pegfilgrastim versus daily filgrastim in Chinese breast cancer patients receiving TAC chemotherapy
Crossref DOI link: https://doi.org/10.1007/s12032-015-0537-7
Published Online: 2015-03-29
Published Print: 2015-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Wei
Jiang, Zhiwei
Wang, Ling
Li, Chanjuan
Xia, Jielai
Text and Data Mining valid from 2015-03-29